These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6085523)

  • 1. Hodgkin's disease: in vitro susceptibility of skin fibroblasts to infection with virus and to lysis by autologous lymphocytes.
    Ebbesen P; Olsson L; Vestergaard BF; Ting R; Haahr S
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):485-95. PubMed ID: 6085523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibilities of normal human skin fibroblasts to oncoviruses, and the decreased susceptibility to HSV of fibroblasts from untreated Hodgkin's patients.
    Ebbesen P; Vestergaard BF; Ting R; Haahr S; Genner J; Svejgaard A
    Br J Cancer; 1981 Jun; 43(6):856-63. PubMed ID: 6166307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective in vitro antibody production to Varicella zoster and other virus antigens in patients with Hodgkin's disease.
    Souhami RL; Babbage J; Sigfusson A
    Clin Exp Immunol; 1983 Aug; 53(2):297-307. PubMed ID: 6309443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibody response in cultures of lymphocytes from patients with Hodgkin's lymphoma: role of monocytes].
    Villa ML; Colleoni M; Valenti F; Tondini C; Clerici E
    Boll Ist Sieroter Milan; 1987; 66(3):214-21. PubMed ID: 3325076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated titer of antibodies to Simian sarcoma virus envelope antigen (gp70) and normal response to influenza virus in untreated Danish Hodgkin's patients.
    Ebbesen P; Due C; Hesse J; Kurth R; Noble GR; Gallagher R; Voller A; Jensen G
    Int J Cancer; 1979 Jul; 24(1):1-5. PubMed ID: 225281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of IgG lymphocytotoxins in untreated Hodgkin's disease (HD) patients.
    Jones DB; Elliott EV; Payne SV; Wright DH
    Clin Exp Immunol; 1978 Oct; 34(1):100-5. PubMed ID: 750114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
    Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
    Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and virological observations in childhood Hodgkin's disease in Israel.
    Bogger-Goren S; Zaizov R; Vogel R; Leventon-Kriss S; Sayar Y; Gotlieb-Stematsky T
    Isr J Med Sci; 1983 Nov; 19(11):989-91. PubMed ID: 6319327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.
    Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD
    Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
    Trinchieri G; Santoli D; Granato D; Perussia B
    Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced viral transformation of skin fibroblasts from neurofibromatosis patients.
    Bidot-Lopez P; Frankel JW
    Ann Clin Lab Sci; 1983; 13(1):27-32. PubMed ID: 6404212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.
    Engleman EG; Benike CJ; Hoppe RT; Kaplan HS; Berberich FR
    J Clin Invest; 1980 Jul; 66(1):149-58. PubMed ID: 6447164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against herpesviruses in patients with Hodgkin's disease.
    Wutzler P; Färber I; Sprössig M; Sauerbrei A; Wutke K; Höche D; Rüdiger KD; Wöckel W; Scheibner K
    Arch Geschwulstforsch; 1983; 53(5):417-22. PubMed ID: 6316868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus.
    Posavad CM; Newton JJ; Rosenthal KL
    J Immunol; 1993 Nov; 151(9):4865-73. PubMed ID: 8409445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of human polyomavirus (JCV, BKV) infections in 139 patients with lung cancer, breast cancer, melanoma, or lymphoma.
    Hogan TF; Padgett BL; Walker DL; Borden EC; Frias Z
    Prog Clin Biol Res; 1983; 105():311-24. PubMed ID: 6304768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of hepatitis G virus infection in Hodgkin's disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection.
    De Renzo A; Persico E; de Marino F; di Giacomo Russo G; Notaro R; di Grazia C; Picardi M; Santoro L; Torella R; Rotoli B; Persico M
    Haematologica; 2002 Jul; 87(7):714-8; discussion 718. PubMed ID: 12091122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
    Haahr S; Møller-Larsen A; Pedersen E
    Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.